SNCA and Parkinson disease: However, if an effective passive immunotherapy to stop PD progression were found, repeated injections would be required, resulting in high costs, and this approach may not be beneficial in the long term, as alpha‐synuclein amyloid fibrils may continue to accumulate, and chronic neuroinflammation would persist.28, 29, 30